Research question
Why do two people with the same anxiety diagnosis, given the same treatment, often have different outcomes?
What the evidence suggests
Anxiety research reports averages. A meta-analysis that finds a moderate effect size for a treatment is describing what happened across a whole group. Inside that average, outcomes vary widely. Some people improve a great deal, some a little, and some not at all. The average doesn't predict where any one person will land.
Several sources of variation are well documented. People differ biologically in how they respond to a given medication. They differ in the severity and duration of their anxiety at the start. They differ in comorbidity, since a person with anxiety plus depression or a substance use disorder often follows a harder course than a person with anxiety alone. They differ in social circumstances, including stress, support, and the ability to attend appointments. And they differ in adherence to the treatment that was prescribed.
This isn't a weakness in the research. It's a real feature of the conditions. It's also why clinical trials report a range and not only an average, and why measures like the number needed to treat exist. Those measures make explicit that a treatment helps some people and not others.
Important limitations
Most trials are designed for group-level inference. Individual predictive models remain less accurate than average effect estimates, and follow-up windows are often shorter than the course of illness.
Practical interpretation
The honest reading of anxiety research is that it narrows the options and ranks them by average benefit, but it can't make the choice for a specific person. This is the central reason treatment is a collaborative process between patient and clinician, often involving trying a first-line option, measuring the response, and adjusting. A study can inform that process. It can't replace it.
What the evidence doesn't prove
Population-level research can't tell an individual which treatment will work for them. There is no validated test that reliably predicts an individual's response to a specific anxiety treatment in advance. Genetic and biomarker prediction is an active research area, but it isn't yet a routine clinical tool.
Related reading on shrinkMD
For realistic timelines once treatment starts, see how long psychiatric treatment usually takes on shrinkMD.
shrinkMD is part of The Shrink Network, founded by Shariq Refai, MD, who is also this site's medical editor.
Sources
How to cite this page
Short
AnxietyResearch.org (2026). Why outcomes vary between individuals. Medically reviewed by Shariq Refai, MD, MBA. https://anxietyresearch.org/treatment-research/why-outcomes-vary/
APA
Refai, S. (2026, May 18). Why outcomes vary between individuals. AnxietyResearch.org. https://anxietyresearch.org/treatment-research/why-outcomes-vary/
MLA
Refai, Shariq. "Why outcomes vary between individuals." AnxietyResearch.org, 18 May 2026, https://anxietyresearch.org/treatment-research/why-outcomes-vary/.
Related reading
Your next step in The Shrink Network
Each site in the network has one job. No matter where you enter, we help you find the next step that makes sense.
Your next step in The Shrink Network
You are here: AnxietyResearch, the evidence layer of The Shrink Network.
Each site in the network has one job. No matter where you enter, we help you find the next step that makes sense.
Get clinical care at shrinkMDWant to understand more first?